Clinical Trial Update: Effect of Multispecies Probiotic Supplementation on the Efficacy of Rifaximin α Therapy in Patients With Small Intestinal Bacterial Overgrowth (SIBO): a Randomized Placebo-controlled Trial [Phase 4]

View source ↗

Summary

A Phase 4 randomized, placebo-controlled trial is investigating whether multispecies probiotic supplementation improves the efficacy of rifaximin therapy in pat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome
• Small Intestinal Bacterial Overgrowth

Drugs mentioned

• Rifaximin (rifaximin)
• multispecies probiotic supplement (probiotic (multispecies))

Snippet

Sponsor: Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji | Conditions: Small Intestinal Bacterial Overgrowth Syndrome (SIBO), IBS | Phase 4 | Status: NOT_YET_RECRUITING